NCTA Webinar: Marijuana Rescheduling – What DOT-Regulated Employers Need to Know

Topic: Marijuana Rescheduling – What DOT-Regulated Employers Need to Know

Overview:
President Trump’s recent Executive Order to reschedule marijuana from a Schedule I substance (no legitimate medical use) to a Schedule III substance has significant implications for employers—especially those regulated by the Department of Transportation (DOT).

Schedule III drugs have accepted medical uses and a moderate to low potential for physical or psychological dependence. Examples include products containing limited quantities of codeine (such as Tylenol with codeine), anabolic steroids, and ketamine.

Why This Matters:
This change raises important questions for DOT-regulated employers and those managing non-DOT testing programs. Join us for a concise, informative session that will provide the latest guidance and practical steps to keep your programs compliant.

Key Takeaways:

• Current updates from ODAPC and NDASA
• What DOT-regulated employers need to know
• Considerations for non-DOT employee testing programs
• Actionable guidance for policy adjustments

Date & Time:

Thursday, January 29th 10:00 AM

Speaker:
Kim Claytor
Compliance Director / Sales Manager
FleetSafe Solutions

Who Should Attend:
NCTA members responsible for compliance, HR, or safety programs.

Register Now to ensure you have the most up-to-date information and actionable guidance.